Cargando…
Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy
We compared lesion-based sensitivity of dual-time-point FDG-PET/CT, bone scintigraphy (BS), and low-dose CT (LDCT) for detection of various types of bone metastases in patients with metastatic breast cancer. Prospectively, we included 18 patients with recurrent breast cancer who underwent dual-time-...
Autores principales: | Hansen, Jeanette Ansholm, Naghavi-Behzad, Mohammad, Gerke, Oke, Baun, Christina, Falch, Kirsten, Duvnjak, Sandra, Alavi, Abass, Høilund-Carlsen, Poul Flemming, Hildebrandt, Malene Grubbe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601566/ https://www.ncbi.nlm.nih.gov/pubmed/34793550 http://dx.doi.org/10.1371/journal.pone.0260066 |
Ejemplares similares
-
Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer
por: Baun, Christina, et al.
Publicado: (2018) -
Higher Interrater Agreement of FDG-PET/CT than Bone Scintigraphy in Diagnosing Bone Recurrent Breast Cancer
por: Holm, Jorun, et al.
Publicado: (2020) -
FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review
por: Helland, Fredrik, et al.
Publicado: (2019) -
FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond
por: Hildebrandt, Malene Grubbe, et al.
Publicado: (2019) -
Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study
por: Gerke, Oke, et al.
Publicado: (2017)